Generate Biomedicines, Inc.

GENB·NasdaqGS·Healthcare
Compare
13.84−0.50 (−3.49%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours13.81−0.03 (−0.22%)Oct 12, 5:26 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close14.34
Open14.34
Day range13.8114.37
52-week range11.0022.67
Off day high−3.69%
Off 52-week high−38.95%
Volume673.90K
Avg. volume (3M)1.05M
Market cap1.78B
EPS (TTM)-2.44
Forward P/E-6.07
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding128.35M
Short interest9.92% of float
Earnings dateAug 6, 2026 (est.)
Analyst target27.00
Profit margin0.00%

Against its peers

Compare in full ›
GENB DNA PBLS PGEN CADL KARD
Market cap 1.78B 793.94M 3.58B 2.74B 748.35M 1.34B
P/E (TTM) — — — — — —
Forward P/E -6.1 -4.1 -13.2 -34.8 -15.6 -4.9
Price/book 3.9 1.8 3.4 62.8 5.9 2.2
Dividend yield — — — — — —
1-year change +13.36% −1.22% −13.04% +143.30% +53.63% −33.32%
Today −3.49% −9.31% +5.35% −1.92% −1.61% −2.18%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GENB news ›
synbiobeta.com·Positive

Synthetic Biology in the Open

Researchers are sharing open source equipment designs, protocols, and code, but what is the synthetic biology community building with them? Synthetic biology is rooted in the idea that engineering principles of standardization, modularity,…

Markets Daily·Positive

Head to Head Review: Generate Biomedicines (GENB) vs. Its Rivals

Posted by Michael Walen on Oct 4th, 2026 Generate Biomedicines (NASDAQ:GENB – Get Free Report) is one of 853 public companies in the “Biotechnology” industry, but how does it compare to its rivals? We will compare Generate Biomedicines to…

Markets Daily·Positive

Analyzing Generate Biomedicines (GENB) & Its Rivals

Posted by Tristan Rich on Oct 2nd, 2026 Generate Biomedicines (NASDAQ:GENB – Get Free Report) is one of 852 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare Generate…

From articles in the 4Search news index.

In the news

3mentions in 30 days
3with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.